KRAS and non-small cell lung carcinoma: However, in NSCLC cells overexpressing mutated KRAS, we observed an additive effect on cell proliferation and apoptosis upon the combination of miR-34c-3p overexpression and exposure to RO03306, a small molecule inhibitor of CDK1.